NovoCure Competitors and Similar CompaniesClear all

NovoCure's competitors and similar companies include Accuray and Zymeworks.

	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.	Accuray Accuray is a radiation therapy company that develops, manufactures, sells, and supports radiation treatment solutions.	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Founding Date	Founding Date 2000	Founding Date 1990	Founding Date 2003
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech medical devices oncology platform therapy	Tags Manufacturing & Industrial medical devices medtech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more	Locations Madison, US HQ Chengdu, CN Kowloon, HK Tokyo, JP Morges, CH Santa Clara, US Sunnyvale, US	Locations Vancouver, CA HQ Seattle, US
Employees	Employees 1,488	Employees 9874% decrease	Employees 45519% increase
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) 186.5 m	Valuation ($) 973.3 m
Financial
Revenue (est.)	Revenue (est.) $655.4m (FY, 2025)	Revenue (est.) $458.5m (FY, 2025)	Revenue (est.) $106m (FY, 2025)
Cost of goods	Cost of goods $166.9m (FY, 2025)	Cost of goods $311.5m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $488.5m (FY, 2025)	Gross profit $147m (FY, 2025)	Gross profit N/A
Net income	Net income ($136.2m) (FY, 2025)	Net income ($1.6m) (FY, 2025)	Net income ($81.1m) (FY, 2025)